MyCancerHaven

MyCancerHaven is committed to empowering cancer patients through a patient-centric, custom-designed, and moderated cloud-based platform. We strive to reduce disparities in cancer care by providing a range of resources, including dissemination of information, educational and research initiatives, and tools for patients to form communities with their peers and find sanctuary with their family and friends.

Website l Twitter


 

CLL and MCL: Experts Discuss the Use of Pirtobrutinib

236 views
May 7, 2024

Chapters

BTK Inhibitors & Pirtobrutinib's Role

00:00

Transitional Therapies: Overcoming BTK Resistance

03:32

MCL: FDA Approval & BRUIN Study Results

04:12

Pirtobrutinib Integration in MCL Treatment

08:02

CLL Treatment: Trial Design & Patient Demographics

09:23

CLL: Efficacy & Durability of Responses on Pirtobrutinib

12:26

Treatment Sequencing & Future of CLL Therapy

14:24

Comments 0
Login to view comments. Click here to Login